SCHEMBL20087724

SCHEMBL20087724

CCCC(C)(CC)S(=O)(=O)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSIP1 O75475 1/20 0.45
HSD11B1 P28845 2/20 0.40
TDP1 Q9NUW8 2/20 0.40
SMN1; SMN2 Q16637 2/20 0.38
HTR6 P50406 1/20 0.37
ALDH1A1 P00352 4/20 0.36
NPSR1 Q6W5P4 1/20 0.36
CYP2C19 P33261 1/20 0.36
HTR1A P08908 2/20 0.35
DRD2 P14416 2/20 0.35
HTR2A P28223 2/20 0.35
HTR7 P34969 2/20 0.35
HTR1B P28222 1/20 0.35
NR1I2 O75469 1/20 0.35
NR1H2 P55055 1/20 0.35
MMP1 P03956 1/20 0.34
MMP2 P08253 1/20 0.34
MMP3 P08254 1/20 0.34
PDE4A P27815 1/20 0.34
PDE4B Q07343 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23195341 0.88 PSIP1 (0.52) PSIP1HSD11B1TDP1SMN1; SMN2HTR6
SCHEMBL22952850 0.82 TDP1 (0.42) TDP1SMN1; SMN2ALDH1A1NPSR1CYP2C19
SCHEMBL18852692 0.81 PSIP1 (0.48) PSIP1HSD11B1TDP1SMN1; SMN2HTR6
SCHEMBL25062242 0.80 TDP1 (0.46) PSIP1HSD11B1TDP1SMN1; SMN2ALDH1A1
SCHEMBL21364029 0.78 CA1 (0.44) HSD11B1SMN1; SMN2ALDH1A1MMP1MMP2
SCHEMBL13703524 0.76 PSIP1 (0.52) PSIP1HSD11B1TDP1SMN1; SMN2HTR6
SCHEMBL24160936 0.76 LMNA (0.44) TDP1ALDH1A1TSHR
SCHEMBL6053419 0.76 PSIP1 (0.47) PSIP1HSD11B1TDP1SMN1; SMN2HTR6
SCHEMBL28138720 0.75 HSD11B1 (0.45) PSIP1HSD11B1TDP1ALDH1A1CYP2C19
SCHEMBL19335680 0.75 CA1 (0.46) HTR6ALDH1A1CYP2C19HSD17B10CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018075699-A1 OXYSTEROLS AND METHODS OF USE THEREOF SAGE THERAPEUTICS, INC. (US) 2018-04-26 WO disclosed